Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Nature Medicine2015Vol. 21(3), pp. 231–238
Citations Over TimeTop 1% of 2015 papers
Benjamin G. Bitler, Katherine M. Aird, Azat Garipov, Hua Li, Michael Amatangelo, Andrew V. Kossenkov, D. Schultz, Qin Liu, Ie‐Ming Shih, José R. Conejo-García, David W. Speicher, Rugang Zhang
Related Papers
- → Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers(2015)669 cited
- → SWI/SNF catalytic subunits’ switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells(2018)55 cited
- → Abstract A18: Targeting epigenetic dysregulation in bladder cancer through inhibition of EZH2(2020)
- → Abstract NT-114: CATALYTIC SUBUNITS SWITCH DRIVES RESISTANCE TO EZH2 INHIBITORS IN ARID1A-MUTATED CELLS(2019)
- → Decision letter: Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers(2017)